You are here: vision-research.eu » News
A revolutionary cortical vision device, developed by Monash University researchers that could one day help restore vision to the blind, is being prepared for world-first human clinical trials in Melbourne.
Intravitreal injection of human retinal progenitor cells (hRPCs; jCell) is a novel treatment in development for retinitis pigmentosa (RP) that has demonstrated promising biologic activity and an excellent safety profile in a recently completed phase 2b study.
While there is no cure for blindness and macular degeneration, scientists have accelerated the process to find a cure by visualizing the inner workings of the eye and its diseases at the cellular level.
Cynthia Matossian, MD, FACS, explains why she believes if ophthalmologists consistently evaluate the ocular surface, tear film and lid margins—and treat any problems that we find—surgical outcomes will improve.
During the current pandemic, we've all been advised to protect ourselves from infection by the SARS-CoV-2 virus that causes COVID-19 by masking, physical distancing and frequent hand-washing. In the Sept. 17 issue of JAMA Ophthalmology, a research team in China suggests that a fourth defensive measure also might be helpful: eye protection.
Two recent studies by a University at Buffalo researcher could help increase safety and minimize expense for patients undergoing glaucoma surgery.
Commission appoints independent Search Committee and invites nominations and applications to fill the post of the next President of the ERC
Science and politics are inseparable — and Nature will be publishing more politics news, comment and primary research in the coming weeks and months.
Johns Hopkins Medicine researchers have created a gel-based eyedrop that responds to the eye's temperature and allows drugs to remain longer on the eye surface, penetrating tissues more effectively without obscuring vision. Tested in mice, rabbits and pigs, the formulation could reduce the number of times a day that patients need to reach for the eye dropper.
Subretinal transplantation of human embryonic stem cells-derived retinal pigment epithelial (RPE) cells in patients with age-related macular degeneration (AMD) and geographic atrophy (GA) appears well tolerated, according to Christopher D. Riemann, MD, of Cincinnati Eye Institute and University of Cincinnati in Ohio.
The ophthalmic community is mourning the loss of Alan S. Crandall, MD, a fixture at the John A. Moran Eye Center at the University of Utah for nearly four decades.
Emmanuelle Charpentier and Jennifer Doudna share the award for developing the precise genome-editing technology.
Best vitelliform macular degeneration, or Best disease, is an inherited eye condition that typically leads to blindness over the course of a few decades. The disease can be caused by more than two hundred mutations in the BEST1 gene.
Twelve cities from nine countries are in the final stage of the contest to become the European Capital of Innovation 2020. Funded by Horizon 2020, EU’s research and innovation programme, the prize recognises the European cities that develop vibrant innovation ecosystems to address public challenges and improve the lives of the people.
A Korean research team has reported important findings that could potentially improve the performance of retinal prostheses, creating artificial vision for blind individuals.
vision-research.eu is kindly supported by ROCHE
Home | Contact | Sitemap | Data protection declaration | Imprint | © 2020 European Vision Institute EEIG, Belgium | info@vision-research.eu